Skip to main content
Daniela Solzbacher

Daniela Solzbacher, MD, Dr med

Languages spoken: English, German

Academic Information

Departments Primary - Psychiatry

Divisions: Adult Psychiatry

Board Certification

  • American Board of Psychiatry & Neurology (Psychiatry)
  • German Medical Association (Otolaryngology, Head and Neck Surgery)

Daniela Solzbacher, MD, Dr. med., Assistant Professor (Clinical), earned her medical degree at the Heinrich-Heine-University of Dusseldorf, Germany in 2001. She completed residency training in Otolaryngology at the University Hospital of Essen, Germany, and is board certified in Otolaryngology. She practiced as an ENT surgeon in Germany until 2010. She completed her psychiatry specialty training at the University of Utah and is board certified in Psychiatry. She joined the faculty at the University of Utah in 2016.

Dr. Solzbacher is the Medical Director of the Treatment Resistant Mood Disorders Clinic and ECT/TMS/Ketamine Services at the University of Utah Huntsman Mental Health Institute. She offers inpatient and outpatient consultations for patients with refractory mood disorders and is a provider for neuromodulation techniques including electroconvulsive therapy (ECT) and transcranial magnetic stimulation (TMS), and Ketamine treatments for depression.

Education History

Certification Duke University School of Medicine
Certification
Chief Resident University of Utah School of Medicine
Chief Resident
Residency University of Utah School of Medicine
Resident
Residency Essen University Hospital
Resident
Internship Tulane University School of Medicine
Sub Internship
Doctoral Training Heinrich Heine University Düsseldorf
Dr med
Professional Medical Heinrich Heine University Düsseldorf
MD

Selected Publications

Journal Article

  1. Riis TS, Feldman DA, Kwon SS, Vonesh LC, Koppelmans V, Brown JR, Solzbacher D, Kubanek J, Mickey BJ (2024). Noninvasive Modulation of the Subcallosal Cingulate and Depression With Focused Ultrasonic Waves. Biol Psychiatry, 97(8), 825-834. (Read full article)
  2. Riis TS, Feldman DA, Vonesh LC, Brown JR, Solzbacher D, Kubanek J, Mickey BJ (2023). Durable effects of deep brain ultrasonic neuromodulation on major depression: a case report. J Med Case Rep, 17(1), 449. (Read full article)

Review

  1. Trapp NT, Purgianto A, Taylor JJ, Singh MK, Oberman LM, Mickey BJ, Youssef NA, Solzbacher D, Zebley B, Cabrera LY, Conroy S, Cristancho M, Richards JR, Flood MJ, Barbour T, Blumberger DM, Taylor SF, Feifel D, Reti IM, McClintock SM, Lisanby SH, Husain MM, National Network of Depression Centers Neuromodulation Task Group (2024). Consensus review and considerations on TMS to treat depression: A comprehensive update endorsed by the National Network of Depression Centers, the Clinical TMS Society, and the International Federation of Clinical Neurophysiology. [Review]. Clin Neurophysiol, 170, 206-233. (Read full article)